Epidemiology of respiratory pathogens and expanded panel testing in influenza-like illness and severe acute respiratory infection in Changsha, central China
This study analyzed 11,355 patients in Changsha from October 2023 to March 2026 to characterize the post-pandemic epidemiology of respiratory pathogens, revealing that *Streptococcus pneumoniae* was the most prevalent pathogen, detection rates and co-infections significantly increased with expanded testing panels, and distinct age-specific and severity-related patterns emerged across influenza-like illness and severe acute respiratory infection cases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Respiratory infections are a constant part of human life, causing everything from mild sniffles to life-threatening pneumonia. For decades, doctors and scientists have tracked these illnesses by looking for specific germs, such as the flu virus or the bacteria that cause pneumonia. However, the world changed dramatically after the global pandemic. During those years, strict measures like mask-wearing and social distancing stopped the spread of not just the pandemic virus, but also many other common respiratory germs. When these restrictions were lifted, the return of these other germs did not happen in a simple, predictable way. Instead of everyone getting sick at the same time as before, the germs began to circulate in new patterns, appearing at different times and affecting different age groups. Understanding these new patterns is crucial because it helps health officials know which germs are dangerous, who is most at risk, and how to test patients effectively.
In the city of Changsha, located in central China, a team of researchers set out to map this shifting landscape. They focused on two groups of people: those with influenza-like illness, who have fever and cough but are usually treated at home, and those with severe acute respiratory infection, who are sick enough to be hospitalized. Between October 2023 and March 2026, the team collected samples from over 11,000 patients across seven hospitals. They used a sophisticated testing method that could look for twelve different respiratory pathogens at once, including viruses like influenza and SARS-CoV-2, as well as bacteria like Streptococcus pneumoniae. In 2025, they expanded this test to look for three additional bacteria, allowing them to see if adding more targets to the test changed what they found.
The results revealed a complex picture of how these germs are moving through the population. Overall, about half of the patients tested positive for at least one pathogen. The most common findings were Streptococcus pneumoniae, influenza virus, and rhinovirus. However, the timing of these infections was not uniform. The germs did not all surge together; instead, they arrived in waves that did not overlap perfectly. Influenza showed a strong, clear seasonal pattern, with a massive spike in late 2025. SARS-CoV-2 appeared in two distinct waves before settling into lower activity. Respiratory syncytial virus, which often causes severe illness in young children, remained quiet for most of 2024 before rising significantly in 2025. This staggered return suggests that the post-pandemic world is not simply returning to how it was before, but is instead reshaping how these infections spread.
Age played a decisive role in who got sick and with what. Young children were the most likely to be infected with common respiratory viruses like respiratory syncytial virus and adenovirus. In contrast, the flu virus was most frequently found in teenagers and young adults, while the risk of severe flu increased again in older adults. SARS-CoV-2 positivity rose steadily with age, making older adults a key group for monitoring. A particularly striking pattern emerged for Mycoplasma pneumoniae, a type of bacteria that causes "walking pneumonia." This pathogen peaked sharply in adolescents and young adults, a group that is often overlooked in discussions about severe respiratory illness. Meanwhile, Streptococcus pneumoniae showed a U-shaped pattern, affecting the very young and the very old most frequently.
The study also highlighted that the severity of the illness often depended on what was found in the patient. While the overall rate of finding a pathogen was similar between those with mild illness and those hospitalized, the types of germs differed. Hospitalized patients were much more likely to have Mycoplasma pneumoniae, respiratory syncytial virus, or Streptococcus pneumoniae. A critical finding was the frequency of co-infections, where a patient carries more than one pathogen at the same time. These mixed infections were most common in young children and were primarily a combination of a virus and a bacterium. The data showed that Streptococcus pneumoniae was often the bacterial partner in these mixtures, suggesting that a viral infection might weaken the airways and allow this bacteria to take hold.
One of the most practical discoveries of the study concerned the testing itself. When the researchers added three extra bacterial targets to their test in 2025, the number of positive results jumped significantly. The overall positivity rate increased by nearly eight percentage points, but the real change was in the detection of co-infections. The rate of finding mixed infections nearly doubled, rising from about 13 percent to over 23 percent. This happened largely because the expanded test could identify a bacterium called Haemophilus influenzae that the original test missed. This finding suggests that while a standard test is good for routine monitoring, a broader test can reveal a much more detailed and accurate picture of what is happening in severe cases or during unusual outbreaks.
The researchers concluded that understanding respiratory health after the pandemic requires looking beyond simple numbers. It is not enough to know how many people are sick; one must know who is sick, how sick they are, and exactly which combination of germs is causing the trouble. The study showed that different age groups face different risks, that severe illness often involves a mix of viruses and bacteria, and that expanding the scope of testing can uncover hidden layers of infection. These insights provide a clearer guide for health officials as they navigate the new, complex patterns of respiratory disease in the years ahead.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.